Moreover, Chu et al. reported that ALOX12 expression is downregulated in many cancer types, including cervical carcinoma, head and neck carcinoma, esophageal carcinoma, and acute myeloid leukemia. Here, ALOX12 is linked to acute myeloid leukemia.